Novartis Ag (NVS) Change in Working Capital (2009 - 2026)

Novartis Ag (NVS) has 16 years of Change in Working Capital data on file, last reported at -$787.0 million in Q1 2026.

• Quarterly Change in Working Capital fell 232.07% year-over-year to -$787.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 billion (down 524.76% YoY) and the FY2025 annual result came in at -$26.0 million, up 96.32% from the prior year.
• Change in Working Capital eased to -$787.0 million in Q1 2026 per NVS's latest filing, from -$695.0 million in the prior quarter.
• The five-year high for Change in Working Capital was $456.0 million in Q4 2022, with the low at -$787.0 million in Q1 2026.
• Average Change in Working Capital over 5 years is -$143.5 million, with a median of -$216.0 million recorded in 2024.
• Year-over-year, Change in Working Capital jumped 332.73% in 2024 and plunged 14000.0% in 2025.
• Novartis Ag's Change in Working Capital stood at $456.0 million in 2022, then slumped by 184.21% to -$384.0 million in 2023, then soared by 101.3% to $5.0 million in 2024, then sank by 14000.0% to -$695.0 million in 2025, then slipped by 13.24% to -$787.0 million in 2026.
• Business Quant data shows NVS's Change in Working Capital at -$787.0 million in Q1 2026, -$695.0 million in Q4 2025, and -$272.0 million in Q3 2025.